NL-OMON34606已完成不适用
Assessment of next-morning driving performance after middle of the night administration of zolpidem tartrate sublingual tablet 3.5 mg in healthy adult volunteers: single-center, double-blind, randomized, placebo-controlled, four-way crossover study - Zolpidem sublingual and driving performance
Transcept Farmaceuticals, Inc0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Age 21 till 64
- •Possession of valid driving licence
- •Sufficient driving experience (at least 3000 km/year over the past three years)
排除标准
- •Use of medication that may influence driving performance
- •Excessive use of alcohol, nicotine or cafeine
- •Use of drugs
- •For women: pregnancy
研究者
相似试验
已完成
1 期
Driving Performance After Middle of the Night Administration of 3.5 mg Zolpidem Tartrate Sublingual TabletInsomniaNCT01106859Transcept Pharmaceuticals40
尚未招募
不适用
Predicting driving ability after stroke in an outpatient setting (a pilot study).Stroke - IschaemicStroke - HaemorrhagicStrokeACTRN12609000302257Osborne Park Hospital50
已完成
1 期
A Study to Assess the Effect of Single and Multiple Doses Org 50081 and a Single Dose of Zopiclone on Next-day Driving Ability and Psychomotor Performance in Healthy Volunteers. (P05794) (COMPLETED)Sleep Initiation and Maintenance DisordersMental DisordersNCT00798395Merck Sharp & Dohme LLC32
已完成
不适用
Measurement of relevant driving skills with active participation in road trafficDRKS00013289Charité - Universitätsmedizin BerlinForschungsgruppe Geriatrie40
已完成
不适用
An observational study to evaluate driving competence in Huntington's diseaseHuntington's diseasemovement disorder10028037NL-OMON43584Centre for Human Drug Research90